Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dyspnea in dying patients

D H Hsu1

  • 1Seymour Medical Clinic, Vancouver.

Canadian Family Physician Medecin De Famille Canadien
|July 1, 1993
PubMed
Summary

Managing dyspnea in terminally ill patients often requires general symptom relief measures. Both non-drug and drug interventions, like morphine, can help but may cause side effects such as sedation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circular fringe carrier technique in holographic interferometry.

Applied optics·2010
Same author

A humanized anti-CD3 antibody, HuM291, with low mitogenic activity, mediates complete and reversible T-cell depletion in chimpanzees.

Transplantation·1999
Same author

HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro.

Transplantation·1999
Same author

Pharmacology and safety assessment of humanized monoclonal antibodies for therapeutic use.

Toxicologic pathology·1999
Same author

A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.

European journal of immunology·1996
Same author

A unique pattern of lymphokine synthesis is a characteristic of certain antigen-specific suppressor T cell clones.

International immunology·1994

Area of Science:

  • Palliative Care
  • Symptom Management

Background:

  • Dyspnea is a prevalent and challenging symptom in terminally ill patients.
  • Effective control of dyspnea is crucial for patient comfort and quality of life.

Purpose of the Study:

  • To outline general strategies for managing dyspnea when specific causes are untreatable.
  • To discuss the utility and limitations of non-drug and drug-based interventions for dyspnea relief.

Main Methods:

  • Review of general palliative care principles for symptom management.
  • Discussion of non-pharmacological approaches, including patient communication.
  • Evaluation of pharmacological options, specifically morphine, for dyspnea control.

Main Results:

  • Non-drug measures like patient discussion can provide symptomatic relief.
  • Pharmacological interventions, such as morphine, are effective for dyspnea.
  • Potential side effects, including sedation, necessitate careful monitoring of drug therapies.

Conclusions:

  • A multimodal approach combining non-drug and drug measures is often necessary for effective dyspnea management in terminal illness.
  • Careful consideration of potential side effects is essential when selecting and administering treatments for dyspnea.

Related Experiment Videos